title: Prognostic significance of myelodysplasia-related changes according to the WHO classification among ELN-intermediate-risk AML patients.
authors.affiliation: Hematology Department, Institut Paoli Calmettes, Marseille, France; Aix-Marseille University, Marseille, France.
authors.forename: Raynier
authors.initials: R
authors.lastname: Devillier
authors.forename: Véronique
authors.initials: V
authors.lastname: Gelsi-Boyer
authors.forename: Anne
authors.initials: A
authors.lastname: Murati
authors.forename: Thomas
authors.initials: T
authors.lastname: Prebet
authors.forename: Jérôme
authors.initials: J
authors.lastname: Rey
authors.forename: Anne
authors.initials: A
authors.lastname: Etienne
authors.forename: Evelyne
authors.initials: E
authors.lastname: D'Incan
authors.forename: Aude
authors.initials: A
authors.lastname: Charbonnier
authors.forename: Didier
authors.initials: D
authors.lastname: Blaise
authors.forename: Marie-Joëlle
authors.initials: MJ
authors.lastname: Mozziconacci
authors.forename: Norbert
authors.initials: N
authors.lastname: Vey
mesh_terms: D000328:Adult; D000368:Aged; D018572:Disease-Free Survival; D005060:Europe; D006801:Humans; D007621:Karyotyping; D015470:Leukemia, Myeloid, Acute / Q000145:classification* / Q000235:genetics* / Q000401:mortality / Q000628:therapy; D008875:Middle Aged; D009154:Mutation; D009190:Myelodysplastic Syndromes / Q000145:classification* / Q000235:genetics* / Q000401:mortality / Q000628:therapy; D009687:Nuclear Proteins / Q000235:genetics; D000090243:Nucleophosmin; D011379:Prognosis; D012074:Remission Induction; D012097:Repressor Proteins / Q000235:genetics; D012306:Risk; D014944:World Health Organization; D055815:Young Adult
chemical_list: C473949:ASXL1 protein, human; D009687:Nuclear Proteins; D012097:Repressor Proteins; D000090243:Nucleophosmin